James Hughes, dean of the Bloustein School of Planning & Public Policy at Rutgers University, also said he did not see much duplication to be cut.
“Allergan has a sales staff that deals with their specific products, and Pfizer has its staff for different products. So I would think that staff is going to stay intact,” Hughes said. “It shouldn’t have much of an impact one way or the other on New Jersey.”
Wall Street Journal, November 23
The New Jersey Statewide Data System is pleased to release its updated Postsecondary Employment and Earnings Dashboard. This dashboard uses linked, longitudinal administrative data from the Office of the Secretary of Higher Education and the New Jersey Department of...
The Rutgers Master of Health Administration program (MHA) program has been ranked #26 in the nation in the 2026 U.S. News & World Report rankings, climbing two spots from last year and continuing a steady rise from #32 in 2024 and #28 in 2025. “We are incredibly...
Evaluating the Use of Google Street View to Visually Verify the Locations of Cannabis Retailers in the United States Extracted from Websites, 2015–2018 Abstract Our ability to advance public health and policy responses to cannabis legalization is limited by a lack of...
Steve Reynolds of Independent Colleges and Universities of New Jersey Guests on Work Trends RU Podcast In the latest episode of Work Trends RU, host Dr. Carl Van Horn speaks with Steve Reynolds, president and CEO of Independent Colleges and Universities of New...
New ‘RU Engaged’ Program Connects First-Year Students to New Brunswick Through Service Rutgers Today, April 3, 2026 A weeklong service program that introduces students to the community will expand next year after its inaugural launch over spring break After eight...